Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2005.03.3225 on March 27 2006

Journal of Clinical Oncology, Vol 24, No 12 (April 20), 2006: pp. 1814-1822
© 2006 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houvenaeghel, G.
Right arrow Articles by Bardou, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houvenaeghel, G.
Right arrow Articles by Bardou, V. J.
Related Articles
Right arrowRelated Editorial

Micrometastases in Sentinel Lymph Node in a Multicentric Study: Predictive Factors of Nonsentinel Lymph Node Involvement—Groupe Des Chirurgiens De La Federation Des Centres De Lutte Contre Le Cancer

Gilles Houvenaeghel, Claude Nos, Hervé Mignotte, Jean Marc Classe, Sylvie Giard, Philippe Rouanet, Frédérique Penault Lorca, Jocelyne Jacquemier, Valérie Jeanne Bardou

From the Institut Paolio Calmettes, Marseille; Institut Curie, Paris; Centre Leon Berard, Lyon; Centre Rene Gauducheau, Nantes Saint-Herblain; Centre Oscard Lambret, Lille; Centre Val D'Aurelle, Montpellier; Centre Jean Perrin, Clermont-Ferrand, France

Address reprint requests to Gilles Houvenaeghel, Institut Paoli Calmettes, 232 Blvd Sainte Marguerite, 13011 Marseille, Cedex 9, France; e-mail: houvenag{at}marseille.fnclcc.fr

PURPOSE: To determine the rate of nonsentinel lymph node (NSN) involvement at axillary lymph node dissection (ALND) and predictive factors of this involvement following detection of micrometastasis in sentinel nodes (SN).

METHODS: We analyzed 700 observations of SN micrometastases with additional ALND with the characteristics of the patients, tumors, and SN.

RESULTS: Involvement of SN was diagnosed 388 times by serial sections (55.4%) with standard hemoxylin and eosin staining (HES) and 312 times solely on immunohistochemical analysis (IHC; 44.6%). The accurate size of the micrometastases was indicated in 488 cases: 301 larger than 0.2 mm (61.7%) and 187 ≤ 0.2 mm (38.3%). Ninety-four patients (13.4%) presented an NSN involvement with only one NSN involved in 62 cases (66%). Predictive factors of NSN involvement were in univariate analysis (pT stage [P < .000], menopausal status [P = .048], T stage [P = .006], grade [P = .013], lymphovascular invasion [LVI; P = .013], histologic tumor type [P = .017], and method of micrometastasis detection, by HES or IHC [P = .015]) and in multivariate analysis (pT stage ≤ or > 20 mm [odds ratio, 2.54], micrometastases detected by HES or IHC [odds ratio,1.734], presence or absence of LVI [odds ratio, 1.706]). Micrometastasis size ≤ or greater than 0.2 mm was not predictive.

CONCLUSION: This study confirms the value of serial sections and the vital role played by IHC in screening for small micrometastases. Omission of additional ALND may be envisaged with minimal risk for pT1a and pT1b tumors, and pT1a-b-c tumors corresponding to tubular, colloidal, or medullar cancers.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Related Editorial

  • Sentinel Node Micrometastases and Non-Sentinel Nodes in Breast Cancer: How Much Do We Need to Know?
    Harry D. Bear
    JCO 2006 24: 1788-1790 [Full Text]


This article has been cited by other articles:


Home page
JCOHome page
H. D. Bear
Completion Axillary Lymph Node Dissection for Breast Cancer: Immediate Versus Delayed Versus None
J. Clin. Oncol., July 20, 2008; 26(21): 3483 - 3484.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
K. A. Vanderveen, R. Ramsamooj, and R. J. Bold
A Prospective, Blinded Trial of Touch Prep Analysis versus Frozen Section for Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer
Ann. Surg. Oncol., July 1, 2008; 15(7): 2006 - 2011.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
J. E. Gervasoni Jr., S. Sbayi, and B. Cady
Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data.
Ann. Surg. Oncol., September 1, 2007; 14(9): 2443 - 2462.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. S. Pugliese, R. Tickman, N. P. Wang, M. Atwood, and J D. Beatty
The Utility of Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer
Ann. Surg. Oncol., March 1, 2007; 14(3): 1024 - 1030.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online